Puma Biotechnology Inc (NYSE:PBYI)

221.30
Data as of Dec 19
 +12.64 / +6.06%
Today’s Change
53.63
Today|||52-Week Range
279.37
+113.75%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$6.7B

Company Description

Puma Biotechnology, Inc. is a development stage biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. The company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. Puma Biotechnology was founded by Alan H. Auerbach on September 15, 2010. Its predecessor company, Innovative Acquisitions Corp was originally incorporated in Delaware in April 2007 as a shell company and later acquired and merged itself into Puma Biotechnology, Inc. in October 2011. The company is headquartered in Los Angeles, CA.

Contact Information

Puma Biotechnology, Inc.
10880 Wilshire Boulevard
Los Angeles California 90024
P:(424) 248-6500
Investor Relations:
142424865002011

Employees

Shareholders

Mutual fund holders50.58%
Other institutional37.47%
Individual stakeholders32.79%

Top Executives

Alan H. AuerbachChairman, President & Chief Executive Officer
Charles R. EylerTreasurer & Senior Vice President-Administration
Richard Paul BryceSenior VP-Clinical Research & Development
Cheryl CollettController
Mariann OhanesianSenior Director-Investor Relations

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.